HER2+ Inflammatory Breast Cancer: Neoadjuvant Approaches
0 Visninger
• 07/03/23
0
0
Indlejre
administrator
Abonnenter
Debu Tripathy, MD, shares insight on the optimal neoadjuvant approaches to HER2+ inflammatory breast cancer with regard to the availability of hormonal and chemotherapeutic agents.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer